Mevion Medical CE Marks S250-FIT Proton Therapy System for Global Use
CE Marking enables marketing and clinical use of the world’s first and only LINAC vault-ready proton therapy system across the European Union Mevion Medical Systems,...
Tag : clinical research
Astellas & Vir Biotech Team on PRO-XTEN® VIR-5500 Cancer Drug
– Astellas and Vir Biotechnology to co-develop and co-commercialize VIR-5500 through a sharing of expenses and revenues – – Astellas to lead commercialization of VIR-5500 in...
Frontier Biotech & GSK License siRNA Therapeutics Globally
Frontier Biotechnologies Inc. (hereinafter referred to as “Frontier Biotech” or “the Company”) has entered into an exclusive licensing agreement with GSK, a global biopharma company. Under the...
Virion Reports Phase 1b Anti-HBV Data at CROI 2026
Virion Therapeutics, LLC, a clinical-stage biotechnology company developing novel T cell-based immunotherapies that utilize checkpoint modifiers, today announced at the 33rd Conference on Retroviruses and Opportunistic Infections (CROI), in Denver, CO,...
YolTech Reports Positive Interim Data on YOLT-202
Single dose of YOLT-202 led to rapid, robust and dose-dependent increases in AAT levels to normal range Single dose of YOLT-202 was well tolerated with...
Manitoba Bioscience Group Applauds Government Support for Research
Bioscience Association Manitoba (BAM) welcomes the Manitoba government’s latest announcement to launch a Clinical Trials Office, and the implementation of the Research Manitoba led project,...
Medtech Industry Establishes Foundation for Clinical Trials with Veeva MedTech
More than 50 medtech companies, including 11 of the top 20, have adopted Veeva clinical applications for greater efficiency and speed Veeva Systems (NYSE: VEEV) today announced that...
Novoviah’s T Cell System Excels in Celiac Disease Detection
Novoviah Pharmaceuticals announces that their novel clinical platform technology for detecting and monitoring disease by measuring immune reactivity has been successfully tested in Celiac Disease,...
Phase 3 MYR301: Bulevirtide Shows Sustained Undetectability
– 90% of Adults with Chronic Hepatitis Delta Virus (HDV) who Achieved Undetectable HDV RNA at 96 Weeks of Treatment with Bulevirtide Remained Undetectable for Almost...
New Algorithm Enables Near T2T Assembly with Oxford Nanopore
New hifiasm-ONT assembly method delivers high-quality, cost-efficient near T2T assemblies using standard Oxford Nanopore Simplex reads, broadening access to comprehensive genome assemblies across research and clinical...
IgniteData Appoints Dr. Jose Galvez as CMIO to Drive Innovation
IgniteData, the leader in eSource to sponsor interoperability for clinical research, is pleased to announce the appointment of Dr. Jose Galvez, MD, former Deputy Director of...
20/20 Onsite Wins TITAN Health Award for Patient-Centric Care
20/20 Onsite has been named a Silver Winner in the 2025 TITAN Health Awards in Provider & Services – Healthcare for Transforming Healthcare Through Patient-Centric, Point-of-Need...
Flatiron Health Joins Veeva to Accelerate Oncology Research
Partnership enhances oncology clinical trial efficiency through streamlined technology integration and long-term strategic collaboration. Flatiron Health, a healthtech company transforming clinical research through solutions that...